COMPANY SUMMARY:
Cygnal, a new biology platform company, was founded by Flagship Pioneering to pioneer the field of exoneural biology – the impact of the peripheral nervous system on cancer, the immune system, metabolism, and regeneration. The company is applying cutting-edge neuroscience to elucidate novel therapies to treat cancer progression and metastasis, autoimmune conditions, inflammation, and other diseases.

Flagship Pioneering conceives, creates, resources, and develops first-in-category life sciences companies to transform human health and sustainability. Since its launch in 2000, the firm has applied a unique hypothesis-driven innovation process to originate and foster more than 100 scientific ventures, resulting in over $30 billion in aggregate value. To date, Flagship is backed by >$3 billion of aggregate capital commitments, of which over $1.4 billion has been deployed toward the founding and growth of its pioneering companies alongside >$10 billion of follow-on investments from other institutions. The current Flagship ecosystem includes Denali Therapeutics (NASDAQ: DNLI), Evelo Biosciences (NASDAQ: EVLO), Moderna Therapeutics (NASDAQ: MRNA), Rubius Therapeutics (NASDAQ: RUBY), Seres Therapeutics (NASDAQ: MCRB), and Syros Pharmaceuticals (NASDAQ: SYRS).

 
POSITION SUMMARY:
Cygnal Therapeutics is seeking a highly motivated and innovative chemical biologist to work at the interface of discovery biology and chemical biology. The successful candidate will report to SVP Small Molecules Drug Discovery and join a cross-functional team responsible for novel target-tool molecule pair ID and validation. Successful candidates should be a self-starter and thrive in a highly collaborative and fast paced environment.
 
KEY RESPONSIBILITIES:
  • Work closely with discovery biology and bioinformatics teams to plan and oversee phenotypic screens and their deconvolution using appropriate MoA studies.
  • Build innovative solutions and enabling capabilities focused on rapid target identification & validation
  • Manage external resources at CROs as well as direct reports on-site
  • Prioritize chemical biology activities and resources to ensure timeline adherence and project alignment with company goals and communicate effectively to discovery partners and senior leadership.
  • Proactively identify sources of inefficiency and solutions, new technologies and lead external collaborations.
 
MINIMUM QUALIFICATIONS:
  • Ph.D. in chemistry or biology with 5+ years of relevant biotech and/or pharmaceutical industry experience leading target ID and validation efforts
  • Demonstrated contributions in target and tool molecule binding site identification and validation
  • Expertise in cell and molecular biology, biochemistry, chemoproteomics and broad understanding of drug discovery
  • Expertise in biochemical and/or biophysical tools to evaluate small molecule drug binding to target protein
  • Expertise in chemistry, especially as it relates to probe design and tissue targeting
  • Proven ability to manage timelines and resources and identify and lead collaborations in chemical biology field
  • Track record of excellence supported by high impact, peer-reviewed publications and/or patents
  • Keen attention to detail with a strong sense of urgency and ability to work in a multi-disciplinary and team-focused environment
  • Excellent communication and presentation skills, capable of conveying technical information in a clear and thorough manner
 
PREFERRED QUALIFICATIONS:
  • Experience in planning, project leadership, laboratory and budget management
  • Experience in the application of genetic and/or computational methods to study pathways and identify targets
  • Ability to manage complexity and ambiguity in a highly matrixed work environment
  • Drug discovery experience in the field of oncology, immuno-oncology or neuroscience
 
RECRUITING & STAFFING AGENCIES: Flagship Pioneering and its affiliated Flagship Lab companies (collectively, “FSP”) do not accept unsolicited resumes from any source other than candidates. The submission of unsolicited resumes by recruitment or staffing agencies to FSP or its employees is strictly prohibited unless contacted directly by Flagship Pioneering’s internal Talent Acquisition team. Any resume submitted by an agency in the absence of a signed agreement will automatically become the property of FSP, and FSP will not owe any referral or other fees with respect thereto.

Apply for this Job

* Required